3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Lymphoma, Large B-Cell, Diffuse
3
Hodgkin Disease
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Uveal Melanoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Glioblastoma
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Gemcitabine
54
130-nm albumin-bound paclitaxel
29
Magnetic Resonance Spectroscopy
21
Taxes
18
Fluorouracil
18
Specimen Handling
17
Oxaliplatin
17
Leucovorin
17
Drug Therapy
17
Albumin-Bound Paclitaxel
17
Irinotecan
14
pembrolizumab
13
Cyclophosphamide
11
Blood Specimen Collection
11
Biopsy
11
fludarabine
10
Radiosurgery
9
irinotecan sucrosofate
8
folfirinox
6
Magnetic Resonance Imaging
6
Cetuximab
6
Bevacizumab
6
dehydroftorafur
5
Surveys and Questionnaires
5
Nivolumab
5
Endoscopic Ultrasound-Guided Fine Needle Aspiration
5
sintilimab
4
olaparib
4
balstilimab
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Neoplasms
×
Carmustine
×
Clear all
NCT04150042
2026-01-29
SHARON
General Oncology, Inc.
Phase 1
Recruiting
24 enrolled